Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 2,833	$ 33,174
Marketable securities	13,547	7,130
Deposits with clearing broker	7,687
Prepaid expenses and other assets	898	564
Prepaid acquisition cost		301
Short-term investments at fair value		13
Notes receivable, at fair value - current portion	3,177	7,474
Investment in Fieldpoint Securities		2,000
Total current assets	28,142	50,656
Property and equipment, net	344
Notes receivable, at fair value - non-current portion	1,129	1,100
Investments	24,150	23,103
Right-of-use assets	3,335	919
Security deposit	458	458
Total assets	57,558	76,236
Current liabilities
Accounts payable and accrued expenses	1,036	447
Accrued salaries and benefits	51	1,260
Accrued commissions	77
Lease liability - current	421	82
Other current liability	22
Total current liabilities	1,607	1,789
Lease liability	3,028	680
Total liabilities	4,635	2,469
Stockholders’ equity
Preferred stock value
Common stock, $0.0001 par value, 100,000,000 shares authorized; 5,995,065 and 5,485,096 shares issued at December 31, 2023 and 2022, respectively; 5,934,917 and 5,017,079 shares outstanding at December 31, 2023 and 2022, respectively
Additional paid-in capital	262,187	262,970
Treasury stock, at cost, 60,148 and 468,017 shares at December 30, 2023 and December 31, 2022, respectively	(501)	(3,322)
Accumulated deficit	(208,763)	(185,881)
Total stockholders’ equity	52,923	73,767
Total liabilities and stockholders’ equity	57,558	76,236
Series D Preferred Stock
Stockholders’ equity
Preferred stock value
Series D-1 Preferred Stock
Stockholders’ equity
Preferred stock value